Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹315 Cr
Revenue (TTM)
₹87 Cr
Net Profit (TTM)
₹10 Cr
ROE
18.8 %
ROCE
19.2 %
P/E Ratio
26.8
P/B Ratio
3.7
Industry P/E
26.81
EV/EBITDA
16
Div. Yield
0 %
Debt to Equity
0.9
Book Value
₹53.8
EPS
₹10.2
Face value
10
Shares outstanding
11,933,000
CFO
₹-26.34 Cr
EBITDA
₹33.20 Cr
Net Profit
₹26.24 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Trident Lifeline
| -15.1 | -1.9 | -17.3 | -1.2 | 18.4 | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Trident Lifeline
| 9.4 | 50.2 | 51.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Trident Lifeline
|
263.9 | 314.9 | 87.0 | 10.5 | -- | 18.8 | 26.8 | 3.7 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 7,827.5 | 19,544.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 97.3 | 23.5 | |
| 1,565.8 | 11,917.5 | 2,089.5 | 622.0 | 31.3 | 20.4 | 19.4 | 3.6 | |
| 1,499.2 | 9,167.3 | 1,196.4 | 149.4 | -- | 27.5 | 61.3 | 13.1 | |
| 1,332.1 | 18,429.0 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.7 | 5.1 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 4,887.1 | 22,333.8 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.2 | 5.6 | |
| 4,778.6 | 7,918.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27 | 11.4 | |
| 971.2 | 8,938.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.5 | 3.0 |
No Review & Analysis are available.
Manufacturing and marketing of quality finished dosages
Incorporated
2014
Chairman
Hardik Jigishkumar Desai
Managing Director
Shravan Harikrishna Patel
Headquarters
Surat, Gujarat
Website
Looking for more details about Trident Lifeline Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Trident Lifeline Ltd is ₹263.90 (BSE) as of 02-Apr-2026 IST. Trident Lifeline Ltd has given a return of 18.37% in the last 3 years.
The P/E ratio of Trident Lifeline Ltd is 26.81 times as on 02-Apr-2026, a 0 premium to its peers’ median range of 26.81 times.
The P/B ratio of Trident Lifeline Ltd is 3.66 times as on 02-Apr-2026, a 21 discount to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.16
|
4.78
|
|
2024
|
29.71
|
3.77
|
|
2023
|
30.41
|
4.07
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Trident Lifeline Ltd are Rs 328.00 and Rs 229.95 as of 04-Apr-2026.
Trident Lifeline Ltd has a market capitalisation of ₹ 315 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Trident Lifeline Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-2.35
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.